Surgery after Induction Targeted Therapy and Immunotherapy for Lung Cancer

Surgery after Induction Targeted Therapy and Immunotherapy for Lung Cancer

Multimodality therapy for locally advanced non-small cell lung cancer (NSCLC) is a complex and controversial issue, especially regarding optimal treatment regimens for patients with ipsilateral positive mediastinal nodes (N2 disease). Many trials investigating neoadjuvant immunotherapy and targeted...

Full description

Bibliographic Details
Main Authors: Toon Allaeys, Lawek Berzenji, Paul E. Van Schil
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Cancers
Subjects:
non-small cell lung cancer
immunotherapy
targeted therapy
surgery
Online Access:https://www.mdpi.com/2072-6694/13/11/2603

Internet

https://www.mdpi.com/2072-6694/13/11/2603

Similar Items